» Articles » PMID: 32275287

COVID-19 in Italy: Impact of Containment Measures and Prevalence Estimates of Infection in the General Population

Overview
Journal Acta Biomed
Specialty General Medicine
Date 2020 Apr 11
PMID 32275287
Citations 131
Authors
Affiliations
Soon will be listed here.
Abstract

Since the beginning of the COVID-19 epidemic in Italy, the Italian Government implemented several restrictive measures to contain the spread of the infection. Data shows that, among these measures, the lockdown implemented as of 9 March had a positive impact, in particular  the central and southern regions of Italy, while other actions appeared to be less effective. When the true prevalence of a disease is unknown, it is possible estimate it, based on mortality data and the assumptive case-fatality rate of the disease. Given these assumptions, the estimated period-prevalence of COVID-19 in Italy varies from 0.35% in Sicity to 13.3% in Lombardy.

Citing Articles

Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients.

Yurdakul F, Bodur H, Cengiz A, Durmaz Y, Duruoz M, Kaya T Arch Rheumatol. 2024; 39(2):203-212.

PMID: 38933732 PMC: 11196221. DOI: 10.46497/ArchRheumatol.2024.10313.


Change in disease burden associated with influenza and air pollutants during the COVID-19 pandemic in Hong Kong.

Liu Y, Jingyu X, Cihan C, Tsang H, Lu S, He D Digit Health. 2024; 10:20552076241261892.

PMID: 38882249 PMC: 11179508. DOI: 10.1177/20552076241261892.


Perceived urban green spaces and youth mental health in the post-COVID-19 era.

Mollaesmaeili M, Hakimian P, Lak A Front Public Health. 2024; 12:1265682.

PMID: 38384876 PMC: 10879616. DOI: 10.3389/fpubh.2024.1265682.


Changing the stroke network during pandemic scenarios does not affect the management of patients with a positive Cincinnati prehospital stroke scale.

Fagoni N, Bellini L, Bonora R, Botteri M, Migliari M, Pagliosa A Neurol Sci. 2023; 45(2):655-662.

PMID: 37672177 PMC: 10791942. DOI: 10.1007/s10072-023-07046-7.


Exact inference for disease prevalence based on a test with unknown specificity and sensitivity.

Cai B, Ioannidis J, Bendavid E, Tian L J Appl Stat. 2023; 50(11-12):2599-2623.

PMID: 37529562 PMC: 10388830. DOI: 10.1080/02664763.2021.2019687.


References
1.
Signorelli C, Odone A, Oradini-Alacreu A, Pelissero G . Universal Health Coverage in Italy: lights and shades of the Italian National Health Service which celebrated its 40th anniversary. Health Policy. 2019; 124(1):69-74. DOI: 10.1016/j.healthpol.2019.11.002. View

2.
Anderson R, Heesterbeek H, Klinkenberg D, Hollingsworth T . How will country-based mitigation measures influence the course of the COVID-19 epidemic?. Lancet. 2020; 395(10228):931-934. PMC: 7158572. DOI: 10.1016/S0140-6736(20)30567-5. View

3.
Boccia S, Ricciardi W, Ioannidis J . What Other Countries Can Learn From Italy During the COVID-19 Pandemic. JAMA Intern Med. 2020; 180(7):927-928. DOI: 10.1001/jamainternmed.2020.1447. View

4.
Lazzerini M, Putoto G . COVID-19 in Italy: momentous decisions and many uncertainties. Lancet Glob Health. 2020; 8(5):e641-e642. PMC: 7104294. DOI: 10.1016/S2214-109X(20)30110-8. View

5.
Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J . The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. J Travel Med. 2020; 27(3). PMC: 7184469. DOI: 10.1093/jtm/taaa037. View